Literature DB >> 22378795

Acquired immunogenicity of human DNA damaged by N-hydroxy-N-acetyl-4-aminobiphenyl.

Uzma Shahab1, Saheem Ahmad, Kiran Dixit, S M Abbas Abidi, Khursheed Alam, Asif Ali.   

Abstract

4-Aminobiphenyl, a known carcinogen, has many environmental sources like cigarette smoke, industrial waste, and so forth. It can be metabolized to form a potent mutagen, N-hydroxy-N-acetyl-4-aminobiphenyl (N-OH-AABP) that undergoes further processing to form electrophilic nitrenium ions which interact with DNA-forming covalent adducts, thereby exerting genotoxic effects. While the mutagenicity of N-OH-AABP has been amply reported, no extensive studies have been performed to assess the immunogenicity of N-OH-AABP-modified DNA. In this study, human placental DNA was modified with N-OH-AABP, and the structural perturbations in the DNA molecule were evaluated by ultraviolet spectroscopy and nuclease S1 digestion. Native and N-OH-AABP-modified DNA were used as antigens for immunizing female rabbits. The modified DNA was found to be highly immunogenic, eliciting high titer immunogen-specific antibodies, while the native form was almost nonimmunogenic. The induced antibodies exhibited wide range of heterogeneity in recognizing various nucleic acid conformers and DNA bases. We also detected deposits of immune complex in glomerular basement membrane in rabbits immunized with N-OH-AABP-DNA. Possible role of N-OH-AABP-DNA in the induction of antibodies in cancer patients and the related consequences have been discussed.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378795     DOI: 10.1002/iub.1008

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  8 in total

1.  Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products.

Authors:  Jalaluddin Mohammad Ashraf; Gulam Rabbani; Saheem Ahmad; Qambar Hasan; Rizwan Hasan Khan; Khursheed Alam; Inho Choi
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

2.  Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.

Authors:  Saheem Ahmad; Uzma Shahab; Mohd Hassan Baig; Mohd Sajid Khan; M Salman Khan; A K Srivastava; Mohd Saeed
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

3.  An immunohistochemical analysis to validate the rationale behind the enhanced immunogenicity of D-ribosylated low density lipo-protein.

Authors:  Firoz Akhter; M Salman Khan; Sarika Singh; Saheem Ahmad
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

4.  Rosmarinic acid inhibits DNA glycation and modulates the expression of Akt1 and Akt3 partially in the hippocampus of diabetic rats.

Authors:  Ameer Alrubaye; Majid Motovali-Bashi; Mehran Miroliaei
Journal:  Sci Rep       Date:  2021-10-18       Impact factor: 4.379

5.  N-OH-AABP Modifications in Human DNA May Lead to Auto-Antibodies in Bladder Cancer Subjects.

Authors:  Uzma Shahab; Safia Habib; Ahmad Alsulimani; Qurain Turki Alshammari; Abdulrahman A Alatar; Shafiul Haque; Moin Uddin; Saheem Ahmad
Journal:  Diagnostics (Basel)       Date:  2022-01-28

6.  Genotoxic effect of N-hydroxy-4-acetylaminobiphenyl on human DNA: implications in bladder cancer.

Authors:  Uzma Shahab; Saheem Ahmad; Kiran Dixit; Safia Habib; Khursheed Alam; Asif Ali
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

7.  Biochemical and immunological parameters as indicators of osteoarthritis subjects: role of OH-collagen in auto-antibodies generation.

Authors:  Jalaluddin M Ashraf; Quazi S Haque; Shams Tabrez; Inho Choi; Saheem Ahmad
Journal:  EXCLI J       Date:  2015-09-23       Impact factor: 4.068

8.  Autoimmune response to AGE modified human DNA: Implications in type 1 diabetes mellitus.

Authors:  Saheem Ahmad; Moin Uddin; Safia Habib; Uzma Shahab; Khursheed Alam; Asif Ali
Journal:  J Clin Transl Endocrinol       Date:  2014-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.